Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory Failure
Acute Respiratory Failure
About this trial
This is an interventional treatment trial for Acute Respiratory Failure focused on measuring Acute Respiratory Failure, Mechanical Ventilation, NAVA, Lung protective ventilation, invasive ventilation, noninvasive ventilation
Eligibility Criteria
Inclusion Criteria:
- Age greater than or equal to 18 years
- Hypoxemic or hypercapnic acute respiratory failure
- Intubation and mechanical ventilation
- Anticipated mechanical ventilation equal or longer than 72 hrs
- Mechanically ventilated less or equal to 5 days
- Able to spontaneously trigger the ventilator
Exclusion Criteria:
- moderate-to-severe acute respiratory distress syndrome
- Post-operative patient's normally requiring a short course of mechanical ventilation (for example most cardiac surgical patients)
- Unable to spontaneously breathe
- Need to provide controlled ventilation
- Poor short term prognosis (defined as a high risk of death in the next 3 months)
- Neuromuscular or neurologic disease
- Age < 18 years
- Patients with major esophageal, gastric and oral surgery
- Acute brain injury or elevated intracranial pressure (> 18 mmHg)
- Severe cardiac disease: New York Heart Association class 3 or 4 or acute coronary syndrome or persistent ventricular tachyarrhythmias.
- Pregnancy, must be confirmed by laboratory analysis.
Sites / Locations
- Nanjing Zhongda Hospital Southeast University
- Hospital Universitario NS de Candelaria
- Hospital NS del Prado
- Complejo Hospitalario Universitario de Albacete
- Hospital Virgen de la Luz
- Hospital Universitario Ramón y Cajal
- Hospital Fundación Jiménez Díaz
- Hospital Universitario La Paz
- Hospital Universitario Morales Meseguer
- Hospital Universitario Virgen de Arrixaca
- Hospital Virgen de la Salud
- Hospital Clinico de Valencia
- Hospital Universitario Rio Hortega
- Hospital Txagorritxu
Arms of the Study
Arm 1
Arm 2
Other
Other
Conventional Lung Protective Ventilation
NAVA Ventilation Group
In this group, patients will be ventilated in either volume A/C, pressure A/C, pressure support, pressure regulated volume control or volume support based on the discretion of the medical team with TV 4-8 ml/kg PBW range and PP or pressure (control or support) level <30 cmH2O.
In the NAVA group, NAVA level will be set initially at zero, then the maximum Edi will be determined as the average level over the next 3 to 5 breaths without ventilatory support or PEEP. The actual NAVA level will then be titrated by the clinician to achieve the following: 1) an Edi equal to approximately 50% of the maximum Edi, 2) an average tidal volume of between 4 to 8 ml/kg predicted body weight (PBW), and 3) an average respiratory rate between about 15 and 40 per minute. In addition, the trigger sensitivity should be set as sensitive as possible without causing auto-triggering and the maximum pressure limit in NAVA should be set at 40 cm H2O.